186 related articles for article (PubMed ID: 33693301)
1. Effects of inflammatory pain on CB1 receptor in the midbrain periaqueductal gray.
Wilson-Poe AR; Wiese B; Kibaly C; Lueptow L; Garcia J; Anand P; Cahill C; MorĂ³n JA
Pain Rep; 2021; 6(1):e897. PubMed ID: 33693301
[TBL] [Abstract][Full Text] [Related]
2. Diabetic thermal hyperalgesia: role of TRPV1 and CB1 receptors of periaqueductal gray.
Mohammadi-Farani A; Sahebgharani M; Sepehrizadeh Z; Jaberi E; Ghazi-Khansari M
Brain Res; 2010 Apr; 1328():49-56. PubMed ID: 20211611
[TBL] [Abstract][Full Text] [Related]
3. Distribution of CB1 cannabinoid receptors and their relationship with mu-opioid receptors in the rat periaqueductal gray.
Wilson-Poe AR; Morgan MM; Aicher SA; Hegarty DM
Neuroscience; 2012 Jun; 213():191-200. PubMed ID: 22521830
[TBL] [Abstract][Full Text] [Related]
4. Cannabinoids and Opioids Differentially Target Extrinsic and Intrinsic GABAergic Inputs onto the Periaqueductal Grey Descending Pathway.
Winters BL; Lau BK; Vaughan CW
J Neurosci; 2022 Oct; 42(41):7744-7756. PubMed ID: 36414010
[TBL] [Abstract][Full Text] [Related]
5. Functional interaction between orexin-1 and CB1 receptors in the periaqueductal gray matter during antinociception induced by chemical stimulation of the lateral hypothalamus in rats.
Esmaeili MH; Reisi Z; Ezzatpanah S; Haghparast A
Eur J Pain; 2016 Nov; 20(10):1753-1762. PubMed ID: 27301294
[TBL] [Abstract][Full Text] [Related]
6. Elevation of endocannabinoid levels in the ventrolateral periaqueductal grey through inhibition of fatty acid amide hydrolase affects descending nociceptive pathways via both cannabinoid receptor type 1 and transient receptor potential vanilloid type-1 receptors.
Maione S; Bisogno T; de Novellis V; Palazzo E; Cristino L; Valenti M; Petrosino S; Guglielmotti V; Rossi F; Di Marzo V
J Pharmacol Exp Ther; 2006 Mar; 316(3):969-82. PubMed ID: 16284279
[TBL] [Abstract][Full Text] [Related]
7. Repeated morphine treatment alters cannabinoid modulation of GABAergic synaptic transmission within the rat periaqueductal grey.
Wilson-Poe AR; Lau BK; Vaughan CW
Br J Pharmacol; 2015 Jan; 172(2):681-90. PubMed ID: 24916363
[TBL] [Abstract][Full Text] [Related]
8. Stress induces analgesia via orexin 1 receptor-initiated endocannabinoid/CB1 signaling in the mouse periaqueductal gray.
Lee HJ; Chang LY; Ho YC; Teng SF; Hwang LL; Mackie K; Chiou LC
Neuropharmacology; 2016 Jun; 105():577-586. PubMed ID: 26907809
[TBL] [Abstract][Full Text] [Related]
9. Mu-opioid and CB1 cannabinoid receptors of the dorsal periaqueductal gray interplay in the regulation of fear response, but not antinociception.
Godoi MM; Junior HZ; da Cunha JM; Zanoveli JM
Pharmacol Biochem Behav; 2020 Jul; 194():172938. PubMed ID: 32376258
[TBL] [Abstract][Full Text] [Related]
10. Sex-specific cannabinoid 1 receptors on GABAergic neurons in the ventrolateral periaqueductal gray mediate analgesia in mice.
Jiang Z; Wang Q; Zhao J; Wang J; Li Y; Dai W; Zhang X; Fang Z; Hou W; Xiong L
J Comp Neurol; 2022 Sep; 530(13):2315-2334. PubMed ID: 35716006
[TBL] [Abstract][Full Text] [Related]
11. Targeting the cannabinoid system for pain relief?
Chiou LC; Hu SS; Ho YC
Acta Anaesthesiol Taiwan; 2013 Dec; 51(4):161-70. PubMed ID: 24529672
[TBL] [Abstract][Full Text] [Related]
12. Positive allosteric modulation of the cannabinoid type-1 receptor (CB1R) in periaqueductal gray (PAG) antagonizes anti-nociceptive and cellular effects of a mu-opioid receptor agonist in morphine-withdrawn rats.
Datta U; Kelley LK; Middleton JW; Gilpin NW
Psychopharmacology (Berl); 2020 Dec; 237(12):3729-3739. PubMed ID: 32857187
[TBL] [Abstract][Full Text] [Related]
13. Investigation of brain sites mediating cannabinoid-induced antinociception in rats: evidence supporting periaqueductal gray involvement.
Lichtman AH; Cook SA; Martin BR
J Pharmacol Exp Ther; 1996 Feb; 276(2):585-93. PubMed ID: 8632325
[TBL] [Abstract][Full Text] [Related]
14. Metamizol, a non-opioid analgesic, acts via endocannabinoids in the PAG-RVM axis during inflammation in rats.
Escobar W; Ramirez K; Avila C; Limongi R; Vanegas H; Vazquez E
Eur J Pain; 2012 May; 16(5):676-89. PubMed ID: 22337336
[TBL] [Abstract][Full Text] [Related]
15. Antiaversive effects of cannabinoids: is the periaqueductal gray involved?
Moreira FA; Aguiar DC; Campos AC; Lisboa SF; Terzian AL; Resstel LB; GuimarĂ£es FS
Neural Plast; 2009; 2009():625469. PubMed ID: 19096514
[TBL] [Abstract][Full Text] [Related]
16. Repeated cannabinoid injections into the rat periaqueductal gray enhance subsequent morphine antinociception.
Wilson AR; Maher L; Morgan MM
Neuropharmacology; 2008 Dec; 55(7):1219-25. PubMed ID: 18723035
[TBL] [Abstract][Full Text] [Related]
17. Actions of cannabinoids on membrane properties and synaptic transmission in rat periaqueductal gray neurons in vitro.
Vaughan CW; Connor M; Bagley EE; Christie MJ
Mol Pharmacol; 2000 Feb; 57(2):288-95. PubMed ID: 10648638
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of fatty acid amide hydrolase unmasks CB1 receptor and TRPV1 channel-mediated modulation of glutamatergic synaptic transmission in midbrain periaqueductal grey.
Kawahara H; Drew GM; Christie MJ; Vaughan CW
Br J Pharmacol; 2011 Jul; 163(6):1214-22. PubMed ID: 21175570
[TBL] [Abstract][Full Text] [Related]
19. Medial prefrontal cortex diclofenac-induced antinociception is mediated through GPR55, cannabinoid CB1, and mu-opioid receptors of this area and periaqueductal gray.
Tamaddonfard E; Erfanparast A; Salighedar R; Tamaddonfard S
Naunyn Schmiedebergs Arch Pharmacol; 2020 Mar; 393(3):371-379. PubMed ID: 31641818
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of fatty-acid amide hydrolase enhances cannabinoid stress-induced analgesia: sites of action in the dorsolateral periaqueductal gray and rostral ventromedial medulla.
Suplita RL; Farthing JN; Gutierrez T; Hohmann AG
Neuropharmacology; 2005 Dec; 49(8):1201-9. PubMed ID: 16129456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]